Ishita Drugs & Industries Ltd has submitted a compliance certificate for the year ended March 31, 2025, confirming that no physical share transfer requests were received during the period.

The company has issued all share certificates within the prescribed timeframe, except for those rejected on technical grounds.

This update reflects efficient management of shareholder services, reinforcing confidence in administrative competencies.

Investors may view this as a positive outlook for operational transparency and shareholder engagement, reducing potential risks related to share transfer processes.